Viewing Study NCT04625595


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-01-03 @ 3:27 AM
Study NCT ID: NCT04625595
Status: COMPLETED
Last Update Posted: 2021-08-25
First Post: 2020-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
Sponsor: Immunomolecular Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type1 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes View
None prescreening View
None autoimmunity View
None HLA View